Page last updated: 2024-08-16

canrenoic acid and thromboxane a2

canrenoic acid has been researched along with thromboxane a2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beitinger, F; Bystron, M; De Toni, EN; Gerbes, AL; Hartmann, AC; Hennenberg, M; Steib, CJ	1

Other Studies

1 other study(ies) available for canrenoic acid and thromboxane a2

Article	Year
Amiloride reduces portal hypertension in rat liver cirrhosis. Gut, 2010, Volume: 59, Issue:6 Topics: Amiloride; Animals; Antihypertensive Agents; Canrenoic Acid; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hypertension, Portal; Kupffer Cells; Liver Cirrhosis, Experimental; Male; Portal Pressure; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Sodium Channel Blockers; Thromboxane A2	2010

Article

Year

Amiloride reduces portal hypertension in rat liver cirrhosis.

Gut, 2010, Volume: 59, Issue:6

Topics: Amiloride; Animals; Antihypertensive Agents; Canrenoic Acid; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hypertension, Portal; Kupffer Cells; Liver Cirrhosis, Experimental; Male; Portal Pressure; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Sodium Channel Blockers; Thromboxane A2

2010